Neuroone Medical Technologies (NMTC) Revenue (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.34% |
| Dec 31, 2025 | 5.53% |
| Sep 30, 2025 | 61.61% |
| Jun 30, 2025 | 22.32% |
| Mar 31, 2025 | -57.65% |
| Dec 31, 2024 | 1,102.48% |
| Sep 30, 2024 | -67.03% |
| Jun 30, 2024 | -40.04% |
| Mar 31, 2024 | 40.88% |
| Dec 31, 2023 | 31.80% |
| Sep 30, 2023 | 17.76% |
| Jun 30, 2023 | 35.12% |
| Mar 31, 2023 | 306.86% |
| Dec 31, 2022 | 66.57% |
| Sep 30, 2022 | 114.63% |
| Jun 30, 2022 | -12.40% |
| Mar 31, 2022 | 8.40% |
| Dec 31, 2021 | -30.18% |
| Sep 30, 2021 | 20.55% |
| Jun 30, 2021 | 119.82% |
| Mar 31, 2021 | -74.48% |
| Jun 30, 2014 | 83.64% |
| Jun 30, 2013 | 11.08% |
| Mar 31, 2013 | 12.78% |
| Dec 31, 2012 | 1,465.22% |
| Mar 31, 2012 | -50.51% |
| Dec 31, 2011 | -63.42% |